APA

Borazan M., Karalezli A., Akova Y. A., Akman A., Kiyici H. & Erbek S. S. (20091106). Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. : Acta ophthalmologica.

Chicago

Borazan Mehmet, Karalezli Aylin, Akova Yonca Aydin, Akman Ahmet, Kiyici Halil and Erbek Selim S. 20091106. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. : Acta ophthalmologica.

Harvard

Borazan M., Karalezli A., Akova Y. A., Akman A., Kiyici H. and Erbek S. S. (20091106). Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. : Acta ophthalmologica.

MLA

Borazan Mehmet, Karalezli Aylin, Akova Yonca Aydin, Akman Ahmet, Kiyici Halil and Erbek Selim S. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. : Acta ophthalmologica. 20091106.